The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Role of Interleukin-6 in Depressive Disorder
Open accessAbstract
Major depressive disorder (MDD), which is a leading psychiatric illness across the world, severely affects quality of life and causes an increased incidence of suicide. Evidence from animal as well as clinical studies have indicated that increased peripheral or central cytokine interleukin-6 (IL-6) levels play an important role in stress reaction and depressive disorder, especially physical disorders comorbid with depression. Increased release of IL-6 in MDD has been found to be a factor associated with MDD prognosis and therapeutic response, and may affect a wide range of depressive symptomatology. However, study results of the IL6 genetic effects in MDD are controversial. Increased IL-6 activity may cause depression through activation of hypothalamic-pituitary-adrenal axis or influence of the neurotransmitter metabolism. The important role of neuroinflammation in MDD pathogenesis has created a new perspective that the combining of blood IL-6 and other depression-related cytokine levels may help to classify MDD biological subtypes, which may allow physicians to identify the optimal treatment for MDD patients. To modulate the IL-6 activity by IL-6-related agents, current antidepressive agents, herb medication, pre-/probiotics or non-pharmacological interventions may hold great promise for the MDD patients with inflammatory features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 2×
“With the 184 amino acid mature segment and a 28 amino acid signal sequence included, the IL6 gene encodes a precursor protein with a total of 212 amino acids in length [7,8].”
BackgroundChronic stress and age-related increases in the proinflammatory cytokine IL-6.
Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B., & Glaser, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531903100 · Cited by 1,267 · cited 1×
“In a longitudinal community study assessing the relationship between chronic stress (caregiving for a spouse with dementia) and IL-6 production, it was found that caregivers′ average rate of increase in IL-6 was about four times as large as that of non-caregivers [28].”
BackgroundImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
Maes, M. H. J., Kubera, M., & Leunis, J. (2008) · PubMed · Cited by 740
Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson, N. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.011 · Cited by 691
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622 · cited 1×
“did not find any effects of tricyclic antidepressants on serum IL-6 levels in MDD patients [105].”
BackgroundRecombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
Iwata, M., Ota, K. T., & Duman, R. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.008 · Cited by 580 · cited 1×
“Many physical diseases are comorbid with depression, mainly cancer and inflammatory diseases associated with higher risks of developing depression [58,59].”
BackgroundNg, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30487-6 · Cited by 572
Gimeno, D., Kivimäki, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G. D. O., Rumley, A., Marmot, M. G., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003723 · Cited by 561
Stimulation of systemic low-grade inflammation by psychosocial stress.
Rohleder, N. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000049 · Cited by 497
Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., Pearce, B. D., Landry, J., Glover, S., McDaniel, J. S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1252 · Cited by 445
Maes, M., Scharpé, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J., & Cosyns, P. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90027-e · Cited by 439
Inflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Effects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 306
Role of interleukin-6 in stress, sleep, and fatigue
Rohleder, N., Aringer, M., & Boentert, M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06634.x · Cited by 289
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
Integrating Interleukin-6 into depression diagnosis and treatment
Hodes, G. E., Ménard, C., & Russo, S. J. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.003 · Cited by 271
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Computational identification of gene–social environment interaction at the human IL6 locus
Cole, S. W., Arevalo, J. M. G., Takahashi, R., Sloan, E. K., Lutgendorf, S. K., Sood, A. K., Sheridan, J. F., & Seeman, T. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911515107 · Cited by 256
Jeon, S. W., & Kim, Y. K. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.283 · Cited by 247
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Hao, Z., Wang, W., Guo, R., & Liu, H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.025 · Cited by 242 · cited 1×
“Some preclinical studies had demonstrated that probiotics, which have potential antidepressant properties, can attenuate stress-inducing IL-6 [141,142].”
BackgroundSukoff Rizzo, S. J., Neal, S. J., Hughes, Z. A., Beyna, M., Rosenzweig-Lipson, S., Moss, S. J., & Brandon, N. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.120 · Cited by 241
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors
Chourbaji, S., Urani, A., Inta, I., Sanchis-Segura, C., Brandwein, C., Zink, M., Schwaninger, M., & Gass, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.001 · Cited by 241
Voorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., Sheridan, J. F., Eubank, T. D., & Marsh, C. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058488 · Cited by 236 · cited 1×
“A recent study using prolonged restraint stress in mice also found increased circulating Il6 mRNA expression [15].”
BackgroundRole of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice
Bluthé, R. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00269-9 · Cited by 235
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215
Rethorst, C. D., Toups, M. S., Greer, T. L., Nakonezny, P. A., Carmody, T. J., Grannemann, B. D., Huebinger, R. M., Barber, R. C., & Trivedi, M. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.125 · Cited by 211
Caruso, R., Nanni, M. G., Riba, M., Sabato, S., Mitchell, A. J., Croce, E., & Grassi, L. (2017) · Acta Oncologica · doi:10.1080/0284186x.2016.1266090 · Cited by 203
Yang, J.-J., Wang, N., Yang, C., Shi, J.-Y., Yu, H.-Y., & Hashimoto, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.021 · Cited by 202
Interleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
Lutgendorf, S. K., Weinrib, A. Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E. S., Henderson, P. J., Sephton, S. E., Rohleder, N., Lucci, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1978 · Cited by 200
Low-grade inflammation predicts persistence of depressive symptoms
Zalli, A., Jovanova, O., Hoogendijk, W. J. G., Tiemeier, H., & Carvalho, L. A. (2016) · Psychopharmacology · doi:10.1007/s00213-015-3919-9 · Cited by 193
Duivis, H. E., de Jonge, P., Penninx, B. W., Na, B. Y., Cohen, B. E., & Whooley, M. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081163 · Cited by 191
Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., Patel, M., Hodes, G. E., Russo, S. J., Merad, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.31 · Cited by 186
Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.112 · Cited by 182
Monje, F. J., Cabatic, M., Divisch, I., Kim, E.-J., Herkner, K. R., Binder, B. R., & Pollak, D. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1537-11.2011 · Cited by 178
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174
Abe, H., Hidaka, N., Kawagoe, C., Odagiri, K., Watanabe, Y., Ikeda, T., Ishizuka, Y., Hashiguchi, H., Takeda, R., Nishimori, T., et al. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.06.1465 · Cited by 160
Fu, X., Zunich, S. M., O’Connor, J. C., Kavelaars, A., Dantzer, R., & Kelley, K. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-43 · Cited by 149
Schrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A. I., Goodheart, M. J., Dahmoush, L., Penedo, F. J., Lucci, J. A., et al. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.07.022 · Cited by 141
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Maes, M., Anderson, G., Kubera, M., & Berk, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888417 · Cited by 140
Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139
Engler, H., Brendt, P., Wischermann, J., Wegner, A., Rohling, R., Schoemberg, T., Meyer, U., Gold, R., Peters, J., Benson, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.264 · Cited by 135
Kitamura, A., Hasegawa, G., Obayashi, H., Kamiuchi, K., Ishii, M., Yano, M., Tanaka, T., Yamaguchi, M., Shigeta, H., Ogata, M., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00844.x · Cited by 125
Kruse, J. L., Congdon, E. L., Olmstead, R., Njau, S. N., Breen, E. C., Narr, K. L., Espinoza, R. T., & Irwin, M. R. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11597 · Cited by 119
Khandaker, G. M., Zammit, S., Burgess, S., Lewis, G., & Jones, P. B. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.11.020 · Cited by 118 · cited 1×
“indicated that a common functional variant in the IL6R gene (IL6R Asp358Ala; rs2228145 A > C), which is able to decrease inflammation by impairing IL-6R signaling, is associated with depression risk [99].”
BackgroundAnti-Depressive Effectiveness of Baicalin In Vitro and In Vivo
Liu, L., Dong, Y. J., Shan, X., Li, L., Xia, B., & Wang, H. (2019) · Molecules · doi:10.3390/molecules24020326 · Cited by 112
Restraint stress elevates the plasma interleukin-6 levels in germ-free mice
Nukina, H., Sudo, N., Aiba, Y., Oyama, N., Koga, Y., & Kubo, C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00260-0 · Cited by 109
Depression, cytokines, and pancreatic cancer
Breitbart, W., Rosenfeld, B., Tobias, K., Pessin, H., Ku, G. Y., Yuan, J., & Wolchok, J. (2014) · Psycho-Oncology · doi:10.1002/pon.3422 · Cited by 106
Bossola, M., Stasio, E. D., Giungi, S., Rosa, F., & Tazza, L. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.07.009 · Cited by 104
Hung, K., Wu, C.-C., Chen, H.-S., Ma, W., Tseng, C., Yang, L.-K., Hsieh, H.-L., & Lu, K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq411 · Cited by 101
Sun, Y., Wang, D., Salvadore, G., Hsu, B., Curran, M., Casper, C., Vermeulen, J., Kent, J. M., Singh, J., Drevets, W. C., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.06.014 · Cited by 100
Recognition and diagnosis of atypical depression.
Thase, M. E. (2007) · PubMed · Cited by 99
Tsai, S.-J. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.001 · Cited by 98
Anderson, G., Kubera, M., Duda, W., Lasoń, W., Berk, M., & Maes, M. H. J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71526-3 · Cited by 98
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 97
Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.006 · Cited by 94
Stress activation of IL-6 neurons in the hypothalamus
Jankord, R., Zhang, R., Flak, J. N., Solomon, M. B., Albertz, J., & Herman, J. P. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00131.2010 · Cited by 94
Kakeda, S., Watanabe, K., Katsuki, A., Sugimoto, K., Igata, N., Ueda, I., Igata, R., Abe, O., Yoshimura, R., & Korogi, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-28300-5 · Cited by 88
Soygür, H., Palaoǧlu, Ö., Akarsu, E. S., Cankurtaran, E. Ş., Özalp, E., Turhan, L., & Ayhan, I. H. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.001 · Cited by 86
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
Kang, H.-J., Bae, K.-Y., Kim, S.-W., Kim, J.-T., Park, M.-S., Cho, K.-H., & Kim, J.-M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.07.001 · Cited by 86
Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients
Fan, N., Luo, Y., Ou, Y., & He, H. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2588 · Cited by 85 · cited 1×
“indicated that IL-6 levels are positively associated with Hamilton Depression Scale-17 scores for MDD patients [52].”
BackgroundJehn, C., Becker, B., Flath, B. C., Nogai, H., Vuong, L. G., Schmid, P., & Lüftner, D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.08.012 · Cited by 83
Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress
Girotti, M., Donegan, J. J., & Morilak, D. A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.004 · Cited by 82
Jehn, C. F., Kühnhardt, D., Bartholomae, A., Pfeiffer, S., Schmid, P., Possinger, K., Flath, B. C., & Lüftner, D. (2010) · Integrative Cancer Therapies · doi:10.1177/1534735410370036 · Cited by 79
Järventausta, K., Sorri, A., Kampman, O., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., Leinonen, E. V. J., Peltola, J., & Lehtimäki, K. A. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12665 · Cited by 78
Liu, H., Zhang, Y., Gao, Y., & Zhang, Z. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.022 · Cited by 77
Skalkidou, A., Sylvén, S. M., Papadopoulos, F. C., Olovsson, M., Larsson, A. O., & Poromaa, I. S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.003 · Cited by 76
Jehn, C., Flath, B. C., Strux, A., Krebs, M., Possinger, K., Pezzutto, A., & Lüftner, D. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2311-2 · Cited by 74
Walsh, E., Eisenlohr-Moul, T., & Baer, R. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000122 · Cited by 72
Interleukin-6 and depressive symptom severity in response to physical exercise
Lavebratt, C., Herring, M. P., Liu, J. J., Wei, Y. B., Bossoli, D., Hallgren, M. Å., & Forsell, Y. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.03.012 · Cited by 72
Rudolf, S., Greggersen, W., Kahl, K. G., Hüppe, M., & Schweiger, U. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.02.016 · Cited by 71
Yoshimura, R., Hori, H., Ikenouchi, A., Umene‐Nakano, W., Katsuki, A., Atake, K., & Nakamura, J. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2333 · Cited by 68
Immune–inflammatory markers in patients with seasonal affective disorder: effects of light therapy
Leu, S., Shiah, I., Yatham, L. N., Cheu, Y.-M., & Lam, R. W. M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00165-8 · Cited by 67
Epigenetics and Depression: An Update
Lin, E., & Tsai, S. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.07.17.2 · Cited by 67
Self-citationTartter, M., Hammen, C., Bower, J. E., Brennan, P. A., & Cole, S. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.01.003 · Cited by 66
Interleukin‐6 and interleukin‐17 are related to depression in patients with rheumatoid arthritis
Li, Y., Chou, Y., Chen, H., Lu, C., & Chang, D. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13529 · Cited by 66
Chocano-Bedoya, P. O., Mirzaei, F., O’Reilly, É. J., Lucas, M., Okereke, O. I., Hu, F. B., Rimm, E. B., & Ascherio, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.023 · Cited by 64
Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and Childhood-Onset Mood Disorders
Misener, V. L., Gomez, L., Wigg, K., Luca, P., King, N. A., Kiss, É., Daróczi, G., Kapornai, K., Tamás, Z., Mayer, L., et al. (2008) · Neuropsychobiology · doi:10.1159/000159775 · Cited by 63
Miranda, D. O., Anatriello, E., de Azevedo, L. R., Cordeiro, J. F. C., Peria, F. M., Flória‐Santos, M., & Pereira-da-Silva, G. (2017) · Cytokine · doi:10.1016/j.cyto.2017.09.030 · Cited by 63
Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial
Del Grande da Silva, G., Wiener, C. D., Barbosa, L. P., Gonçalves Araujo, J. M., Molina, M. L., San Martin, P., Oses, J. P., Jansen, K., Dias de Mattos Souza, L., & Azevedo da Silva, R. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.008 · Cited by 60
Benefits of Yoga on IL-6: Findings from a Randomized Controlled Trial of Yoga for Depression
Nugent, N. R., Brick, L. A. D., Armey, M. F., Tyrka, A. R., Ridout, K. K., & Uebelacker, L. A. (2019) · Behavioral Medicine · doi:10.1080/08964289.2019.1604489 · Cited by 59
Yang, C., Hong, T., Shen, J., Ding, J., DAI, X.-W., ZHOU, Z.-Q., & Yang, J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.930 · Cited by 58
Aniszewska, A., Chłodzińska, N., Bartkowska, K., Winnicka, M. M., Turlejski, K., & Djavadian, R. L. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.001 · Cited by 58
Yang, C., Tiemessen, K. M., Bosker, F. J., Wardenaar, K. J., Lie, J., & Schoevers, R. A. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.05.008 · Cited by 57
Effects of Interleukin-6 on Depression Risk in Dialysis Patients
Sonikian, M. A., Metaxaki, P., Papavasileiou, D., Boufidou, F., Nikolaou, C. C., Vlassopoulos, D., & Vlahakos, D. (2010) · American Journal of Nephrology · doi:10.1159/000285110 · Cited by 54
Perić, I., Stanisavljević, A., Gass, P., & Filipović, D. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0807-9 · Cited by 54
El-Kade, S. M. A., & Al-Jiffri, O. H. (2017) · African Health Sciences · doi:10.4314/ahs.v16i4.25 · Cited by 52
de Punder, K., Entringer, S., Heim, C. C., Deuter, C. E., Otte, C., Wingenfeld, K., & Kuehl, L. K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00610 · Cited by 52
Kovács, D., Eszlári, N., Petschner, P., Pap, D., Vas, S., Kovacs, P. L., Gonda, X., Bagdy, G., & Juhász, G. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1506-9 · Cited by 50
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-104029 · Cited by 50
Ye, G., Yin, G., Tang, Z., Fu, J. L., Chen, J., Chen, S. S., Li, J., Fu, T., Yu, X., Xu, D. W., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718000090 · Cited by 48
Gazal, M., Souza, L. D., Fucolo, B. A., Wiener, C. D., Silva, R. A., Pinheiro, R. T., Jansen, K., Ghislene, G., Oses, J. P., & Kaster, M. P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.002 · Cited by 47
Identification of IL6 as a susceptibility gene for major depressive disorder
Zhang, C., Wu, Z., Zhao, G., Wang, F., & Fang, Y. (2016) · Scientific Reports · doi:10.1038/srep31264 · Cited by 46
The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
Wang, M., Wei, J., Yang, X., Ni, P., Wang, Y., Zhao, L., Deng, W., Guo, W., Wang, Q., Li, T., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s202329 · Cited by 46
Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression
Ryan, J. L., Pilkington, L., Neuhaus, K., Ritchie, K. A., Ancelin, M., & Saffery, R. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1515-8 · Cited by 45
Taraz, M., Khatami, M., Gharekhani, A., Abdollahi, A., Khalili, H., & Dashti‐Khavidaki, S. (2012) · European Cytokine Network · doi:10.1684/ecn.2013.0326 · Cited by 42
Alshogran, O. Y., Khalil, A. A., Oweis, A. O., Altawalbeh, S. M., & Alqudah, M. A. Y. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.04.003 · Cited by 41
Factors of depression among patients with rheumatoid arthritis
Kwiatkowska, B., Kłak, A., Maślińska, M., Mańczak, M., & Raciborski, F. (2018) · Reumatologia/Rheumatology · doi:10.5114/reum.2018.77973 · Cited by 40
Hayley, S. P., Mangano, E. N., Strickland, M., & Anisman, H. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.03.015 · Cited by 36
Depression and IL-6 Blood Plasma Concentrations in Advanced Cancer Patients
Jacobson, C. M., Rosenfeld, B. D., Pessin, H., & BREITBART, W. S. (2008) · Psychosomatics · doi:10.1176/appi.psy.49.1.64 · Cited by 35
The effect of sunlight exposure on interleukin-6 levels in depressive and non-depressive subjects
Levandovski, R. M., Pfaffenseller, B., Carissimi, A., Gama, C. S., & Hidalgo, M. P. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-75 · Cited by 35
Yoshimura, R., Umene‐Nakano, W., Hoshuyama, T., Ikenouchi‐Sugita, A., Hori, H., Katsuki, A., Hayashi, K., Atake, K., & Nakamura, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1155 · Cited by 33
Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study
Roetker, N. S., Yonker, J. A., Lee, C. K., Chang, V., Basson, J., Roan, C., Hauser, T. S., Hauser, R. M., & Atwood, C. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000944 · Cited by 32
The acute phase response: from Hippocrates to cytokine biology.
Kushner, I. (1991) · PubMed · Cited by 31
Shukkoor, M. S. A., Baharuldin, M. T. H., Jais, A. M. M., Moklas, M. A. M., & Fakurazi, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2986090 · Cited by 31
Zhao, C., Ma, H., Yang, L., & Xiao, Y. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s124630 · Cited by 29
Shimura, Y., Kurosawa, H., Tsuchiya, M., Sawa, M., Kaneko, H., Liu, L., Makino, Y., Nojiri, H., Iwase, Y., Kaneko, K., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3826-z · Cited by 28
Prevalence of depression symptoms and serum levels of interleukin‐6 in hemodialysis patients
Knuth, B. S., Radtke, V. A., Rocha, P., da Silva, K. S., Dalsóglio, F., Gazal, M., Jansen, K., Souza, D. O., Portela, L. V., Kaster, M. P., et al. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12130 · Cited by 27
Ushiroyama, T., Ikeda, A., Sakuma, K., & Ueki, M. (2005) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x05003338 · Cited by 27
Meyer, T., Stanske, B., Kochen, M. M., Cordes, A., Yüksel, I., Wachter, R., Lüers, C., Scherer, M., Binder, L., Pieske, B. M., et al. (2011) · Behavioral Medicine · doi:10.1080/08964289.2011.609192 · Cited by 27
Interleukin-6 Genetic Polymorphism and Chinese Major Depression
Hong, C., Yu, Y. W. ‐., Chen, T., & Tsai, S. (2005) · Neuropsychobiology · doi:10.1159/000089003 · Cited by 25
Self-citationInagaki, M., Akechi, T., Okuyama, T., Sugawara, Y., Kinoshita, H., Shima, Y., Terao, K., Mitsunaga, S., Ochiai, A., & Uchitomi, Y. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1767-x · Cited by 24
Ardakani, M. T., Mehrpooya, M., Mehdizadeh, M., Hajifathali, A., & Abdolahi, A. (2015) · PubMed Central · Cited by 22
Depression and serum interleukin-6 levels in patients on dialysis.
Uglešić, B., Ljutić, D., Lasić, D., Jelicić, I., Višić, V., Glavina, T., Šundov, Ž., Puljiz, Ž., Cvitanović, M., & Meter, A. (2015) · PubMed · Cited by 21
Koutsouraki, E., Hatzifilippou, E., Michmizos, D., Cotsavasiloglou, C., Costa, V., & Balogiannis, S. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.4.jnp442 · Cited by 20
Machine Learning in Neural Networks
Lin, E., & Tsai, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_7 · Cited by 20
Self-citationCremeans‐Smith, J. K., Soehlen, S., Greene, K. A., Alexander, T. S., & Delahanty, D. L. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.06.148 · Cited by 19
Pearlman, D. M., Brown, J. R., MacKenzie, T. A., Hernandez, F., & Najjar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111110 · Cited by 19
Augustine, L. F., Nair, K. M., Rao, S. F., Rao, M. V., Ravinder, P., Balakrishna, N., Laxmaiah, A., & Vazir, S. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.875417 · Cited by 14
Tsuboi, H., Sakakibara, H., Tatsumi, A., Yamakawa‐Kobayashi, K., Matsunaga, M., Kaneko, H., & Shimoi, K. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.031 · Cited by 14
Cited by
Lyra e Silva, N. M., Gonçalves, R. A., Pascoal, T. A., Lima-Filho, R. A. S., Resende, E. D. P. F., Vieira, E. L. M., Teixeira, A. L., de Souza, L. C., Peny, J. A., Fortuna, J. T. S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01349-z · Cited by 347
So, W. K. W., Law, B. M. H., Ng, M. S. N., He, X., Chan, D. N. S., Chan, C. W. H., & McCarthy, A. L. (2021) · Cancer Medicine · doi:10.1002/cam4.3794 · Cited by 181
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Metadata
- Authors
- Ting, E. Y.-C., Yang, A. C., & Tsai, S.-J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-22
- Volume
- 21
- Issue
- 6
- Pages
- 2194
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3012729670
- Cited by
- 385
- References
- 140
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.